| 000 | 01855 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514050421.0 | ||
| 264 | 0 | _c20030108 | |
| 008 | 200301s 0 0 eng d | ||
| 022 | _a1931-857X | ||
| 024 | 7 |
_a10.1152/ajprenal.00026.2002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDiPetrillo, Keith | |
| 245 | 0 | 0 |
_aUrinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes. _h[electronic resource] |
| 260 |
_bAmerican journal of physiology. Renal physiology _cJan 2003 |
||
| 300 |
_aF113-21 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAlbuminuria _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xpharmacology |
| 650 | 0 | 4 |
_aAntigens, CD _xmetabolism |
| 650 | 0 | 4 | _aBiomarkers |
| 650 | 0 | 4 | _aCell Separation |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xmetabolism |
| 650 | 0 | 4 |
_aDiabetic Nephropathies _xmetabolism |
| 650 | 0 | 4 | _aEtanercept |
| 650 | 0 | 4 | _aHypertrophy |
| 650 | 0 | 4 |
_aImmunoglobulin G _xpharmacology |
| 650 | 0 | 4 |
_aKidney _xmetabolism |
| 650 | 0 | 4 |
_aKidney Tubules, Distal _xcytology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aOrgan Size |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xmetabolism |
| 650 | 0 | 4 | _aReceptors, Tumor Necrosis Factor, Type I |
| 650 | 0 | 4 | _aReceptors, Tumor Necrosis Factor, Type II |
| 650 | 0 | 4 |
_aSodium _xmetabolism |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aCoutermarsh, Bonita | |
| 700 | 1 | _aGesek, Frank A | |
| 773 | 0 |
_tAmerican journal of physiology. Renal physiology _gvol. 284 _gno. 1 _gp. F113-21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1152/ajprenal.00026.2002 _zAvailable from publisher's website |
| 999 |
_c12197447 _d12197447 |
||